Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis. You can search the database by category, keyword, name, and/or date. Keep abreast of cure research breakthroughs by signing up for our research newsletter.

Register To Receive Updates

Click the button below to register to receive regular updates from MCPF.



To search articles by keyword or date, enter your search criteria in the box and click the Search button.

All Articles
1 2 3 4 5 6 7 8 9 10 ...
 

New trial aiming to repair injured spinal cords gives new hope to paralysed Australians posted Monday, 04 December 2017
Anne-Marie Howarth was riding her motorcycle in the Blue Mountains when she went too fast on a bend, crashed into a barrier and "squashed" her spine, leaving her paralyzed from the lower chest down…
Category: Clinical Trials


A decade after stem cell feat, research ramps up posted Saturday, 18 November 2017
In his UW-Madison lab, Su-Chun Zhang discovered a likely cause of ALS, the deadly neurological disorder also known as Lou Gehrig’s disease, after turning skin cells from ALS patients into stem cells. A protein error in cellular structures called neurofilaments, which transport chemicals that allow muscles to move, leads to paralysis in at least some forms of ALS, Zhang found...
Category: Stem Cells


Regenerative Medicine Restores Movement After Paralysis posted Thursday, 05 October 2017
Twelve-month data from spinal cord injury trial shows two-thirds of subjects recovered two or more motor levels Newswise — Four of six people with paralyzing spinal cord injuries who were treated with a new cell therapy have recovered two or more motor levels on at least one side, new study results show.
Category: Clinical Trials


Asterias Announces Two Significant Developments for Spinal Cord Injury Program posted Monday, 02 October 2017
FREMONT, Calif., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company pioneering the field of regenerative medicine, today announced new 12-month data from the first efficacy cohort in the company’s ongoing Phase 1/2a SCiStar study designated to evaluate safety and efficacy of AST-OPC1...
Category: Clinical Trials


Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study posted Wednesday, 23 August 2017
Source: Asterias Biotherapeutics FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Washington University School of Medicine in St. Louis, MO, has been added as a clinical site in the company’s ongoing SCiStar Phase 1/2a clinical trial of AST-OPC1...
Category: Clinical Trials


NEW SPINAL CORD INJURY REPAIR COMPANY LAUNCHED posted Friday, 18 August 2017
Elizabeth Hofheinz, M.P.H., M.Ed. • Fri, August 18th, 2017 Print this article Based on an innovative technology from Yale University which has shown promise to grow nerve fibers naturally and restore all facets of nerve function, a new company, ReNetX Bio (formerly known as Axerion Therapeutics), has been launched. ReNetX Bio is focused on providing physicians with a novel treatment for...
Category: General


Nerve fibers regenerated with molecular mix posted Thursday, 17 August 2017
By Ana Sandoiu Damage to a neuron's axon, or nerve fiber - the 'long tail' that sends signals from the cell body - is a key element of spinal cord injury. Scientists may have found a way to regrow axons - a crucial part of a neuron also known as a nerve fiber - after injury. The findings may help patients with spinal cord injury, stroke, or other neurodegenerative conditions recover their motor skills. A team of researchers at Boston Children's Hospital in Massachusetts have developed a "recipe" for a mixture of molecules and tested its therapeutic potential in mice with spinal cord injury (SCI) or stroke...
Category: Pharmaceutical


Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial posted Thursday, 10 August 2017
By GlobeNewswire, August 09, 2017, 07:00:00 AM Enrollment for entire SCiStar study expected to be completed by end-2017 FREMONT, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment and dosing of the first patient in the fifth and final cohort in the company's ongoing SCiStar Phase 1/2a clinical study of AST-OPC1 in motor complete cervical spinal cord injury (SCI). This cohort will dose between five and eight patients with AIS-B (motor complete, sensory incomplete) cervical spinal cord injuries with 20 million AST-OPC1 cells...
Category: Clinical Trials


Nipro closing in on stem cell cure for spinal cord injuries posted Saturday, 05 August 2017
OSAKA -- Medical equipment maker Nipro could commercialize next year a stem-cell-based treatment seen allowing people with spinal cord injuries to walk again. The Osaka-based company has carried out joint research with Sapporo Medical University since 2014. They recently found success in trials where stem cells harvested from bone marrow and increased are returned to the body, where they concentrate in injured areas of the spinal cord and regenerate tissue...
Category: Clinical Trials


Surgery can prompt sensory nerves to ‘sprout’ fresh connections to spinal cord posted Wednesday, 02 August 2017
Jamie Seidel, News Corp Australia Network THE quest to repair spinal cord injuries is a medical holy grail. Now, we’re beginning to understand how it could be done. And the fix may already be in our own bodies. A study by Kings College London examined a new surgery technique capable of reconnecting complex sensory neurons to the spinal cord. Specifically, the Frontiers in Neurology study looked at how the spinal cord of a rat went about completing the repair itself...
Category: General

1 2 3 4 5 6 7 8 9 10 ...
Morton Cure Paralysis Fund - Minnesota
5021 Vernon Ave., Suite 145
Minneapolis, MN 55436
(612) 904-1420
info@mcpf.org
Morton Cure Paralysis Fund - Arizona
4939 W. Ray Rd., Suite 4190
Chandler, AZ 85226
(612) 904-1420
info@mcpf.org